Corgentech treatment fails trial Shares plunge after company says its vein graft treatment failed to show benefit in late-stage test. CHICAGO (Reuters) - Biotechnology company Corgentech Inc. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 